ATE348165T1 - Peptide und nachweis zur diagnose von lyme- krankheit und zusammensetzungen zu deren verhütung - Google Patents

Peptide und nachweis zur diagnose von lyme- krankheit und zusammensetzungen zu deren verhütung

Info

Publication number
ATE348165T1
ATE348165T1 AT00926350T AT00926350T ATE348165T1 AT E348165 T1 ATE348165 T1 AT E348165T1 AT 00926350 T AT00926350 T AT 00926350T AT 00926350 T AT00926350 T AT 00926350T AT E348165 T1 ATE348165 T1 AT E348165T1
Authority
AT
Austria
Prior art keywords
peptide
lyme disease
peptides
compositions
preventing
Prior art date
Application number
AT00926350T
Other languages
English (en)
Inventor
Mario T Philipp
Fang Ting Liang
Original Assignee
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tulane filed Critical Univ Tulane
Application granted granted Critical
Publication of ATE348165T1 publication Critical patent/ATE348165T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT00926350T 1999-04-28 2000-04-25 Peptide und nachweis zur diagnose von lyme- krankheit und zusammensetzungen zu deren verhütung ATE348165T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/300,971 US6475492B1 (en) 1999-04-28 1999-04-28 Peptides and assays for the diagnosis of lyme disease

Publications (1)

Publication Number Publication Date
ATE348165T1 true ATE348165T1 (de) 2007-01-15

Family

ID=23161382

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00926350T ATE348165T1 (de) 1999-04-28 2000-04-25 Peptide und nachweis zur diagnose von lyme- krankheit und zusammensetzungen zu deren verhütung

Country Status (8)

Country Link
US (1) US6475492B1 (de)
EP (1) EP1171605B1 (de)
AT (1) ATE348165T1 (de)
AU (1) AU767955B2 (de)
CA (1) CA2370493C (de)
DE (1) DE60032347T2 (de)
ES (1) ES2278605T3 (de)
WO (1) WO2000065064A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2191597A (en) * 1996-02-21 1997-09-10 Board Of Regents, The University Of Texas System Vmp-like sequences of pathogenic borrelia
US6660274B2 (en) * 1997-06-30 2003-12-09 The Administrators Of The Tulane Educational Fund Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease
US20030129680A1 (en) * 2001-10-31 2003-07-10 O'connor Thomas Patrick Multi-analyte assay device
US7087372B2 (en) 2001-01-18 2006-08-08 Idexx Laboratories, Inc. Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US7407770B2 (en) 2001-01-18 2008-08-05 Idexx Corporation Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
WO2004058181A2 (en) 2002-12-20 2004-07-15 Board Of Regents, The University Of Texas System Vmp-like sequences of pathogenic borrelia species and strains
WO2007084568A2 (en) 2006-01-17 2007-07-26 Health Research, Inc. Heteroduplex tracking assay
WO2007133623A2 (en) * 2006-05-10 2007-11-22 Biopeptides Corporation Peptide diagnostic agent for lyme disease
BRPI0817202B1 (pt) 2007-09-21 2018-11-21 Idexx Lab Inc polipeptídeo purificado e método de detecção de anticorpos que se ligam especificamente a um polipeptídio do ehrlichia chaffeensis em uma amostra em teste
MX2010002947A (es) 2007-09-21 2010-08-04 Idexx Lab Inc Metodos y composiciones para deteccion de ehrlichia chaffeensis (p120).
US8313915B2 (en) * 2009-01-21 2012-11-20 Gundersen Lutheran Medical Foundation, Inc. Early detection of canine lyme disease by specific peptides and antibodies
FR2949472B1 (fr) 2009-08-28 2013-08-09 Biomerieux Sa Proteines utilisees pour le diagnostic d'une borreliose de lyme
FR2949473B1 (fr) 2009-08-28 2013-08-09 Biomerieux Sa Proteines utilisees pour le diagnostic d'une borreliose de lyme
WO2011063003A2 (en) 2009-11-17 2011-05-26 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
US8926989B2 (en) * 2010-03-10 2015-01-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Compositions and methods for screening for Lyme disease
US8946393B2 (en) 2010-09-27 2015-02-03 Cornell University Methods for diagnosing lyme disease
WO2013067448A2 (en) 2011-11-03 2013-05-10 Vca Antech Inc. Compositions and methods to detect various infectious organisms
US8758772B2 (en) 2011-11-04 2014-06-24 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
DE102012006498B4 (de) 2012-03-29 2019-08-14 Audi Ag Verfahren zum Betreiben einer Brennkraftmaschine, Brennkraftmaschine sowie Prüfstand
US9500648B1 (en) 2013-03-12 2016-11-22 Robert M. Tate, Jr. Rapid Lyme antigen test for detection of Lyme disease
US11061028B2 (en) 2014-09-24 2021-07-13 Defined Diagnostics, Llc Compositions and methods for the diagnosis of lyme disease
CA2996984C (en) 2015-08-27 2024-01-02 Quidel Corporation Immunoassay test device with two fluid flow paths for detection and differentiation of two or more analytes
WO2017062535A2 (en) 2015-10-06 2017-04-13 Bio-Rad Laboratories, Inc. Borrelia immunoassays and materials therefor
US10401358B1 (en) 2016-09-30 2019-09-03 Ross Southern Laboratories Serodiagnosis of lyme disease by use of two recombinant proteins in ELISA
AU2018219320A1 (en) 2017-02-10 2019-09-19 Quidel Corporation Lateral flow assay with substrate having channels for controlled fluid flow
CN111018998B (zh) * 2019-12-04 2021-10-29 杭州傲锐生物医药科技有限公司 一种莱姆重组融合蛋白OspC-VlsE及其应用
WO2023215783A1 (en) * 2022-05-04 2023-11-09 Kephera Diagnostics, Llc Method for detecting lyme disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK590288D0 (da) * 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
CH485551A (de) 1967-11-02 1970-02-15 Haensel Otto Gmbh Verfahren und Vorrichtung zum Einwickeln von Warenstücken
EP0339695A3 (de) 1988-04-29 1990-05-30 Stichting Voor De Technische Wetenschappen Verfahren zur Herstellung eines antigenen bzw. immunogenen Konjugats sowie die Verwendung solcher Konjugate
CA2072008C (en) 1989-12-22 2003-01-28 Renate Fuchs Immunologically active proteins from borrelia burgdorferi, related test kits which contain these proteins and are suitable for detecting antibodies in test fluids, and the use of these proteins as vaccines against infections caused by borrelia strains
JPH05501113A (ja) 1990-03-05 1993-03-04 アメリカ合衆国 ボレリア　ブルグドルフェリの抗原性タンパク質
CA2084413A1 (en) 1990-06-15 1991-12-16 Richard A. Flavell Compositions and methods for the prevention and diagnosis of lyme disease
DK0465204T3 (da) 1990-07-06 2000-10-09 American Home Prod Vaccine mod Lyme sygdom
AU2191597A (en) * 1996-02-21 1997-09-10 Board Of Regents, The University Of Texas System Vmp-like sequences of pathogenic borrelia
US6660274B2 (en) 1997-06-30 2003-12-09 The Administrators Of The Tulane Educational Fund Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease

Also Published As

Publication number Publication date
CA2370493A1 (en) 2000-11-02
AU4489300A (en) 2000-11-10
AU767955B2 (en) 2003-11-27
CA2370493C (en) 2010-09-21
DE60032347T2 (de) 2007-07-12
DE60032347D1 (de) 2007-01-25
EP1171605B1 (de) 2006-12-13
EP1171605A1 (de) 2002-01-16
WO2000065064A1 (en) 2000-11-02
ES2278605T3 (es) 2007-08-16
US6475492B1 (en) 2002-11-05

Similar Documents

Publication Publication Date Title
ATE348165T1 (de) Peptide und nachweis zur diagnose von lyme- krankheit und zusammensetzungen zu deren verhütung
CA2175567A1 (en) Chimeric proteins comprising borrelia polypeptides: uses therefor
DE60026332D1 (de) Diagnose von einheimischer sprue/zöliakie mit hilfe von gliadinepitopen
KR0176265B1 (en) Causative agent of the mystery swine disease, and vaccine compositions
FR2772047B1 (fr) Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
WO1995014781A3 (en) Methods for diagnosing early lyme disease
DE69718903T2 (de) Verwendung von aus osp-c abgeleiteten peptidefragmenten für diagnostische methoden
CA2224127A1 (en) Flagellin gene, flac of campylobacter
IL152507A0 (en) Methods and compositions for impairing multiplication of hiv-1
CA2332570A1 (en) Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine
ATE189684T1 (de) Rekombinante polypeptide und peptide, dafür kodierende nukleinsäuren und ihre verwendung in der tuberkulose-diagnose
DE1240180T1 (de) Peptide zur diagnose und behandlung rheumatischer arthritis
CA2175332A1 (en) Haemophilus transferrin receptor genes
US6716574B2 (en) Osp-C derived peptide fragments
CN110563802B (zh) 一组含n-甲基化氨基酸及n端脂肪酸修饰的抗菌肽类似物及其合成方法和应用
ATE267397T1 (de) Reagenz zum nachweis und weiterverfolgen von virusinfektionen
GB9021942D0 (en) Hiv related peptides
Cardoso et al. The serology of hepatitis C virus (HCV) infection: antibody crossreaction in the hypervariable region 1
CA2262500A1 (en) Measles virus mutant antigen and gene coding for the same
CA2486345A1 (en) Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species
ATE298347T1 (de) Immunodiagnostischer wirkstoff zum nachweiss von maedi-visna virus und caev infektionen
JP2003189884A5 (de)
JPH0770184A (ja) 牛の小型ピロプラズマ病原虫感染の予防に有効なペプチド

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties